title: Successful laser treatment of vandetanib-associated cutaneous pigmentation.
authors.forename: Sara
authors.initials: S
authors.lastname: Brooks
authors.forename: W Marston
authors.initials: WM
authors.lastname: Linehan
authors.forename: Ramaprasad
authors.initials: R
authors.lastname: Srinivasan
authors.forename: Heidi H
authors.initials: HH
authors.lastname: Kong
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced / Q000628:therapy*; D053844:Lasers, Solid-State / Q000627:therapeutic use*; D010880:Piperidines / Q000009:adverse effects* / Q000627:therapeutic use; D047428:Protein Kinase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use; D012880:Skin Pigmentation / Q000187:drug effects
chemical_list: D000970:Antineoplastic Agents; D010880:Piperidines; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; C452423:vandetanib